A clinical formulation indicated for Erectile Dysfunction. This product facilitates increased blood flow to the pelvic region to support the physiological ability to achieve and maintain an erection.
A PDE5 inhibitor developed to manage erectile dysfunction and intended to alleviate sexual performance issues by supporting blood flow to the penis during stimulation.
Mechanism of Action
It inhibits the PDE5 enzyme, increasing cyclic GMP levels in penile tissues. This relaxes muscles and increases blood flow to facilitate a firm erection.
Route of Administration
Oral
Onset Time
30–60 minutes
Duration
4–6 hours
Contraindications
Concurrent use of nitrates, Severe heart disease, Low blood pressure, Allergy to sildenafil
Information for Cenforce is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
